Establishing the reference intervals of NK cell functions in healthy adults

Human Immunology

Volumn 77, Issue 8, 2016, Pages 637-642

  Hou, Hongyan ^a   Mao, Lie ^a   Wang, Juan ^a   Liu, Weiyong ^a   Lu, Yanfang ^a   Yu, Jing ^a   Zhou, Yu ^a   Mao, Liyan ^a   Wang, Feng ^a   Sun, Ziyong ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

CD107a; IFN ; Natural killer cells; Reference intervals

Indexed keywords

CD3 ANTIGEN; CD56 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; PHORBOL 13 ACETATE 12 MYRISTATE;

ADULT; AGE; ARTICLE; CANCER PATIENT; CELL CULTURE; CELL FUNCTION; CELL STIMULATION; COLORECTAL CANCER; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DEGRANULATION; DEGRANULATION ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENDER; HOST; HUMAN; HUMAN CELL; IMMUNE STATUS; MALE; NATURAL KILLER CELL; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REFERENCE VALUE; SUPERNATANT; UPREGULATION; CELL SEPARATION; COLORECTAL NEOPLASMS; CYTOTOXICITY TEST; IMMUNOLOGY; METABOLISM; MIDDLE AGED; STANDARD; STANDARDS; YOUNG ADULT;

ADULT; CELL SEPARATION; CELLS, CULTURED; COLORECTAL NEOPLASMS; CYTOTOXICITY TESTS, IMMUNOLOGIC; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; FLOW CYTOMETRY; HUMANS; INTERFERON-GAMMA; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; REFERENCE STANDARDS; YOUNG ADULT;

EID: 84971668157     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2016.05.022     Document Type: Article

References (29)

1. [1] Bryceson, Y.T., Chiang, S.C., Darmanin, S., Fauriat, C., Schlums, H., Theorell, J., et al. Molecular mechanisms of natural killer cell activation. J. Innate Immun., 3, 2011, 216.
2. [2] Bryceson, Y.T., March, M.E., Ljunggren, H.G., Long, E.O., Activation, coactivation, and costimulation of resting human natural killer cells. Immunol. Rev., 214, 2006, 73.
3. [3] Whiteside, T.L., Friberg, D., Natural killer cells and natural killer cell activity in chronic fatigue syndrome. Am. J. Med., 105, 1998, 27S.
4. [4] Chung, H.J., Park, C.J., Lim, J.H., Jang, S., Chi, H.S., Im, H.J., et al. Establishment of a reference interval for natural killer cell activity through flow cytometry and its clinical application in the diagnosis of hemophagocytic lymphohistiocytosis. Int. J. Lab. Hematol., 32, 2010, 239.
5. [5] Rook, A.H., Masur, H., Lane, H.C., Frederick, W., Kasahara, T., Macher, A.M., et al. Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome. J. Clin. Invest., 72, 1983, 398.
6. [6] Hansen, K.A., Opsahl, M.S., Nieman, L.K., Baker, J.R. Jr., Klein, T.A., Natural killer cell activity from pregnant subjects is modulated by RU 486. Am. J. Obstet. Gynecol., 166, 1992, 87.
7. [7] Cauda, R., Prasthofer, E.F., Grossi, C.E., Whitley, R.J., Pass, R.F., Congenital cytomegalovirus: immunological alterations. J. Med. Virol., 23, 1987, 41.
8. [8] Konjevic, G., Spuzic, I., Stage dependence of NK cell activity and its modulation by interleukin 2 in patients with breast cancer. Neoplasma, 40, 1993, 81.
9. [9] Tarle, M., Kraljic, I., Kastelan, M., Comparison between NK cell activity and prostate cancer stage and grade in untreated patients: correlation with tumor markers and hormonal serotest data. Urol. Res., 21, 1993, 17.
10. [10] Imai, K., Matsuyama, S., Miyake, S., Suga, K., Nakachi, K., Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. Lancet, 356, 2000, 1795.
11. [11] Portevin, D., Via, L.E., Eum, S., Young, D., Natural killer cells are recruited during pulmonary tuberculosis and their ex vivo responses to mycobacteria vary between healthy human donors in association with KIR haplotype. Cell. Microbiol., 14, 2012, 1734.
12. [12] Pross, H.F., Baines, M.G., Studies of human natural killer cells. I. In vivo parameters affecting normal cytotoxic function. Int. J. Cancer, 29, 1982, 383.
13. [13] Motzer, S.A., Tsuji, J., Hertig, V., Johnston, S.K., Scanlan, J., Natural killer cell cytotoxicity: a methods analysis of 51chromium release versus flow cytometry. Biol. Res. Nurs., 5, 2003, 142.
14. [14] Alter, G., Malenfant, J.M., Altfeld, M., CD107a as a functional marker for the identification of natural killer cell activity. J. Immunol. Methods, 294, 2004, 15.
15. [15] Claus, M., Greil, J., Watzl, C., Comprehensive analysis of NK cell function in whole blood samples. J. Immunol. Methods, 341, 2009, 154.
16. [16] Valiathan, R., Lewis, J.E., Melillo, A.B., Leonard, S., Ali, K.H., Asthana, D., Evaluation of a flow cytometry-based assay for natural killer cell activity in clinical settings. Scand. J. Immunol., 75, 2012, 455.
17. [17] Mhatre, S., Madkaikar, M., Ghosh, K., Desai, M., Pujari, V., Gupta, M., Rapid flow cytometry based cytotoxicity assay for evaluation of NK cell function. Indian J. Exp. Biol., 52, 2014, 983.
18. [18] Cedeno-Arias, M., Sanchez-Ramirez, J., Blanco-Santana, R., Rengifo-Calzado, E., Validation of a flow cytometry based binding assay for evaluation of monoclonal antibody recognizing EGF receptor. Sci. Pharm., 79, 2011, 569.
19. [19] Cooper, M.A., Fehniger, T.A., Caligiuri, M.A., The biology of human natural killer-cell subsets. Trends Immunol., 22, 2001, 633.
20. [20] Cooper, M.A., Fehniger, T.A., Turner, S.C., Chen, K.S., Ghaheri, B.A., Ghayur, T., et al. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood, 97, 2001, 3146.
21. [21] Paul, H., Chris, L.S., Optimized assay for serum angiotensin-converting enzyme activity. Clin. Chem., 27, 1981, 2048.
22. [22] Takeuchi, H., Maehara, Y., Tokunaga, E., Koga, T., Kakeji, Y., Sugimachi, K., Prognostic significance of natural killer cell activity in patients with gastric carcinoma: a multivariate analysis. Am. J. Gastroenterol., 96, 2001, 574.
23. [23] Lee, S.B., Cha, J., Kim, I.K., Yoon, J.C., Lee, H.J., Park, S.W., et al. A high-throughput assay of NK cell activity in whole blood and its clinical application. Biochem. Biophys. Res. Commun., 445, 2014, 584.
24. [24] Abdullah, M., Chai, P.S., Chong, M.Y., Tohit, E.R., Ramasamy, R., Pei, C.P., et al. Gender effect on in vitro lymphocyte subset levels of healthy individuals. Cell. Immunol., 272, 2012, 214.
25. [25] Nagel, J.E., Collins, G.D., Adler, W.H., Spontaneous or natural killer cytotoxicity of K562 erythroleukemic cells in normal patients. Cancer Res., 41, 1981, 2284.
26. [26] Le Garff-Tavernier, M., Beziat, V., Decocq, J., Siguret, V., Gandjbakhch, F., Pautas, E., et al. Human NK cells display major phenotypic and functional changes over the life span. Aging Cell, 9, 2010, 527.
27. [27] Locke, B.A., Dasu, T., Verbsky, J.W., Laboratory diagnosis of primary immunodeficiencies. Clin. Rev. Allergy Immunol., 46, 2014, 154.
28. [28] Chinen, J., Notarangelo, L.D., Shearer, W.T., Advances in basic and clinical immunology in 2013. J. Allergy Clin. Immunol., 133, 2014, 967.
29. [29] Kallal, L.E., Biron, C.A., Changing partners at the dance: Variations in STAT concentrations for shaping cytokine function and immune responses to viral infections. JAKSTAT, 2, 2013, e23504.